What happened

Two of the largest private rounds of the past week landed at almost the same valuation and could hardly be more different.

On October 21, Bloomberg reported that Flapping Airplanes, a San Francisco AI research lab, raised $1 billion at a $6 billion valuation. Index Ventures and Lux Capital led. Sequoia Capital, Alphabet's GV and Kleiner Perkins also took part, and Nvidia (NVDA) is an existing investor. The company was founded in late 2025 and raised a $180 million seed round in January 2026, so the valuation has roughly quadrupled in under a year. It has no product on sale yet, and no revenue figure has been reported. Value Add VC's weekly tracker lists the round as a Series A.

Two days earlier, on October 19, Tenstorrent, the AI chip company led by CEO Jim Keller, announced a $1.5 billion Series E at a $6.2 billion post-money valuation. Trace Capital and Innovation X led. Participants included Fidelity Management & Research Company, ARK Invest, Morgan Stanley, T. Rowe Price, Tether Investments, Sandisk and XTX Markets. Dealroom puts the prior valuation at about $2.6 billion, set at a nearly $700 million Series D in late 2024.

Two ways to price the same number

The headline valuations match. The underwriting does not.

Flapping Airplanes is a bet on a research thesis and a team. According to The Next Web, the lab is working on training models with less data and computing power and on getting more performance out of each chip, and it is writing its own version of the software that runs on Nvidia's graphics chips. It plans to sell its technology eventually. Investors here are paying for option value: if the approach works, the payoff is large, and none of that is yet visible in revenue.

Tenstorrent is a bet on a company that already ships. Its release describes products ranging from single cards and workstations to racks and superclusters, plus licensing of its TT-Ascalon RISC-V CPU and Tensix AI cores to other chip designers. Proceeds are earmarked for deploying its Galaxy servers at scale, serving open-weight models, and advancing the licensed IP. The investor list reads differently too: mutual fund and asset-manager names such as Fidelity and T. Rowe Price sit alongside venture backers, a mix more typical of late-stage rounds than of a lab with a seed round behind it.

The release does not disclose revenue, so outsiders cannot say how much of the $6.2 billion rests on current sales versus future capacity. That gap is worth keeping in mind when reading the round as a validation of the business.

A useful contrast outside AI

The same tracker shows how other sectors raised that week. Stand, an insurtech covering homes in catastrophe-prone regions, raised a $70 million Series C at a $1 billion valuation led by Saga Ventures, bringing its total funding to $130 million. Stand says the property value it covers grew from $1 billion to more than $10 billion in a year. Whop, an internet business platform, raised $200 million in a Series D at a reported $5.1 billion valuation from Sequoia Capital, according to the same tracker.

The point is not that these are better or worse deals. It is that a $1 billion valuation can rest on a $70 million check backed by a stated ten-fold growth in exposure, or sit on a $1 billion check with no product. The number alone says little. What the money is underwriting says a lot.

The rest of the week's top rounds

The same tracker shows how the next tier looked. ASI, an AI infrastructure management software company, raised $325 million in a Series C at a $3 billion valuation, led by Spark Capital. Otter.ai, the meeting tool, raised $320 million in a growth round led by General Catalyst. Pigment raised $250 million in a Series E at a $2.3 billion valuation, led by the Scaleup Europe Fund. Arda Industries, which aims to make production lines more adaptable, drew $232 million from Accel, Altimeter Capital, Founders Fund and Khosla Ventures. Warp Sciences, a drug chemistry company launched by former OpenAI science chief Kevin Weil, raised $215 million in a round led by Lightspeed Venture Partners.

The two in that tier with listed valuations, Pigment and ASI, sit at $2.3 billion and $3 billion, so the two $6 billion rounds stand well above them. The tracker covers US rounds from October 16 to 23 and is not a complete market list, and some of its labels and valuations come from article headlines, so treat the stage names as approximate.

What founders and fund managers should take from it

Do not anchor on the biggest cheques. The Value Add VC top 20 for October 16 to 23 is led by an AI chip maker and an AI lab, with robotics and physical-AI companies well represented; the table is a tracker's selection, not a complete market count. Founders outside those categories are being compared against a different set of investors and different expectations.

Know which story your round tells. Flapping Airplanes sells a thesis, Tenstorrent sells deployed capacity and licensed IP, Stand sells measured growth. Diligence questions follow the story: expect research milestones in the first case, utilization and customer commitments in the second, and loss ratios and growth in covered value in the third.

Watch step-ups. Flapping Airplanes' fourfold move in months and Tenstorrent's roughly doubling over about two years from late 2024 are the kind of marks that later rounds, secondary sales and fund valuations will be measured against. For limited partners, valuations set this quickly raise the bar the next round must clear.

What to watch next

Three things bear watching: whether Flapping Airplanes discloses a first product or commercial timeline, whether Tenstorrent shares revenue or Galaxy deployment figures as it scales, and whether more late-stage rounds bring in public-market asset managers the way Tenstorrent's did. Each would show whether this week's pricing reflects durable demand or a narrow window.

This article is information and commentary only, not investment advice.

Sources